Farms.com Home   News

APHIS Issues Regulatory Status Review Response: Bayer CropScience Corn

The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) recently reviewed a corn plant modified using genetic engineering. We reviewed the plant to determine whether it presented an increased plant pest risk compared to unmodified corn plants. APHIS posted the Regulatory Status Review (RSR) response on our website as required under 7 CFR part 340.

Bayer CropScience LP modified the corn plant to reduce gibberellic acid, a plant growth hormone, to produce shorter plants and reduce the likelihood of lodging (stem buckling).

APHIS found this plant unlikely to pose an increased plant pest risk compared to other cultivated corn plants. As a result, it is not subject to regulation under 7 CFR part 340, and this plant may be safely grown and bred in the United States. 

You can view the RSR request from Bayer CropScience LP and APHIS’ response letter at the link below. Our response is based on information from the developers and our: 

  • familiarity with plant varieties,
  • knowledge of the traits, and
  • understanding of the modifications. 

Under 7 CFR part 340, developers may request an RSR when they believe a modified plant is not subject to regulation. APHIS reviews the modified plant and considers whether it might pose an increased plant pest risk compared to a nonregulated plant. If our review finds a plant is unlikely to pose an increased plant pest risk relative to the comparator plant, APHIS issues a response indicating the plant is not subject to the regulations. 

Source : usda.gov

Trending Video

Unveiling the Future of Agriculture

Video: Unveiling the Future of Agriculture

In this excerpt from the full interview with Keri Carstens she discusses the future of agriculture, in sunny Orlando, Florida, at the 2024 ASTA Field Crop Seed Convention as we take a walk with Keri Carstens, CEO of Jord BioScience. We quiz Keri on the lessons she’s learned in the bio-tech space and what’s ahead in this rapidly evolving market. From navigating regulatory challenges to leadership advice, Keri offers her perspective on the biggest opportunities in bio-tech. Plus, hear her vision for the impact biotech will make in the seed sector in the next five years.